Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AUVI

AUVI - Applied UV, Inc. Stock Price, Fair Value and News

1.84USD-0.04 (-2.13%)Delayed as of 21 Feb 2024, 01:54 pm ET
Watchlist

Market Summary

USD1.84-0.04
Delayedas of 21 Feb 2024, 01:54 pm
-2.13%

AUVI Stock Price

View Fullscreen

AUVI RSI Chart

AUVI Valuation

Market Cap

26.0M

Price/Earnings (Trailing)

-1.34

Price/Sales (Trailing)

0.69

EV/EBITDA

-1.62

Price/Free Cashflow

-2.86

AUVI Price/Sales (Trailing)

AUVI Profitability

Operating Margin

72.01%

EBT Margin

-51.24%

Return on Equity

-108.14%

Return on Assets

-27.16%

Free Cashflow Yield

-34.96%

AUVI Fundamentals

AUVI Revenue

Revenue (TTM)

37.9M

Rev. Growth (Yr)

94.81%

Rev. Growth (Qtr)

5.55%

AUVI Earnings

Earnings (TTM)

-19.4M

Earnings Growth (Yr)

4.73%

Earnings Growth (Qtr)

13.99%

Breaking Down AUVI Revenue

52 Week Range

1.96
(Low)(High)

Last 7 days

-4.9%

Last 30 days

-49.3%

Last 90 days

-47.8%

Trailing 12 Months

-98.6%

How does AUVI drawdown profile look like?

AUVI Financial Health

Current Ratio

0.51

AUVI Investor Care

Shares Dilution (1Y)

286.21%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202327.4M32.4M37.9M0
202212.7M16.7M19.1M20.1M
20216.6M6.8M8.8M11.7M
20208.3M7.4M6.6M5.7M
20190009.1M

Tracking the Latest Insider Buys and Sells of Applied UV, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jul 21, 2023
munn laurie
sold
-
-
-625,000
-
Jan 12, 2023
woo monica l
bought
1,998
1.11
1,800
-
Jan 01, 2023
luhukay joseph fellipus peter
acquired
-
-
7,500
-
Jan 01, 2023
burleson eugene
acquired
-
-
7,500
-
Jan 01, 2023
hack dallas christian
acquired
-
-
7,500
-
Jan 01, 2023
woo monica l
acquired
-
-
7,500
-
Dec 30, 2022
woo monica l
bought
907
0.9077
1,000
-
Dec 30, 2022
woo monica l
sold
-2,203
0.91795
-2,400
-
Dec 27, 2022
woo monica l
bought
5,310
0.901084
5,894
-
Dec 27, 2022
woo monica l
sold
-8,908
0.88201
-10,100
-

1–10 of 26

Which funds bought or sold AUVI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 14, 2024
TWO SIGMA SECURITIES, LLC
sold off
-100
-4,658
-
-%
Feb 14, 2024
LPL Financial LLC
sold off
-100
-7,205
-
-%
Feb 14, 2024
CITADEL ADVISORS LLC
sold off
-100
-38,700
-
-%
Feb 13, 2024
XTX Topco Ltd
sold off
-100
-3,659
-
-%
Feb 13, 2024
Qube Research & Technologies Ltd
new
-
9.00
9.00
-%
Feb 13, 2024
Tower Research Capital LLC (TRC)
sold off
-100
-1,476
-
-%
Feb 13, 2024
Tower Research Capital LLC (TRC)
new
-
1,619
1,619
-%
Feb 13, 2024
GEODE CAPITAL MANAGEMENT, LLC
sold off
-100
-14,689
-
-%
Feb 12, 2024
JPMORGAN CHASE & CO
sold off
-100
-2.00
-
-%
Feb 12, 2024
OSAIC HOLDINGS, INC.
sold off
-100
-11,143
-
-%

1–10 of 21

Are Funds Buying or Selling AUVI?

Are funds buying AUVI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AUVI
No. of Funds

Unveiling Applied UV, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Aug 21, 2023
streeterville capital llc
9.99%
889,672
SC 13G
Feb 07, 2023
stern brian andrew
12.09%
2,015,300
SC 13D
Feb 07, 2023
lawrence andrew webb
13.34%
1,709,967
SC 13G

Recent SEC filings of Applied UV, Inc.

View All Filings
Date Filed Form Type Document
Feb 15, 2024
8-K
Current Report
Dec 26, 2023
DEF 14C
DEF 14C
Dec 18, 2023
8-K
Current Report
Dec 15, 2023
PRE 14C
PRE 14C
Nov 17, 2023
8-K
Current Report
Nov 17, 2023
10-Q
Quarterly Report
Nov 16, 2023
424B4
Prospectus Filed
Nov 14, 2023
S-1MEF
S-1MEF
Nov 14, 2023
NT 10-Q
NT 10-Q
Nov 13, 2023
EFFECT
EFFECT

What is the Fair Value of AUVI?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Applied UV, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
361.1B
153.7B
1.87% 15.30%
23
2.35
-2.27% -8.14%
129.7B
90.2B
3.63% 8.66%
16.92
1.44
-5.98% 14.63%
47.6B
35.9B
-8.22% 43.29%
10.05
1.33
6.66% -16.52%
23.6B
9.5B
2.52% 45.54%
14.85
2.48
-9.58% -7.76%
11.7B
4.4B
4.97% 17.88%
42.04
2.65
6.85% -0.25%
MID-CAP
7.3B
11.2B
13.32% -0.30%
-13.32
0.65
-5.69% -401.61%
6.0B
19.5B
-5.26% -23.57%
12.38
0.31
-1.36% 131.86%
5.9B
2.7B
10.62% 92.09%
23.63
2.13
9.03% 34.51%
3.1B
1.9B
17.07% 30.10%
17.93
1.66
-14.77% -30.65%
2.7B
4.8B
-22.17% -41.56%
12.79
0.57
-9.04% -41.16%
2.7B
3.7B
-0.52% 34.57%
10.47
0.73
-18.06% -50.64%
SMALL-CAP
1.5B
1.9B
2.22% 62.39%
13.04
0.76
-6.39% 700.65%
917.6M
2.1B
-7.53% 95.28%
5.88
0.43
-6.89% -25.76%
135.3M
390.1M
-4.38% -17.98%
-42.68
0.35
-19.66% -104.85%
56.3M
86.7M
16.02% -2.39%
11.94
0.65
9.53% -34.99%

Applied UV, Inc. News

Latest updates
InvestorsObserver14 Feb 202405:48 pm
InvestorsObserver01 Feb 202408:00 am
InvestorsObserver29 Jan 202408:00 am
InvestorPlace12 Jan 202408:00 am
InvestorPlace4 months ago

Applied UV, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q3
Revenue5.6%11,446,04810,843,68610,654,4835,000,5025,875,6115,907,6463,356,0903,919,0803,551,5651,884,3202,312,6151,005,1031,560,6331,695,3641,471,6342,123,7412,775,848
Cost Of Revenue--------1,438,7533,996,053--5,098,5743,281,5491,180,7691,161,813--
Gross Profit10.2%2,655,2842,409,6941,922,386746,789838,6141,303,7921,149,0991,585,2661,051,401533,229924,266106,74278,178514,595309,8211,021,2561,175,561
Operating Expenses0.1%5,105,0735,102,4125,453,58910,105,6843,598,6194,113,2644,298,7434,354,4642,683,0252,708,2451,645,1622,434,688968,972528,284388,198-740,038
  S&GA Expenses1.9%5,013,9884,922,1195,264,3794,166,5303,505,0974,031,2153,101,2264,354,4642,683,0252,698,4821,601,5172,570,367624,228426,677388,198539,282740,038
  R&D Expenses-49.5%91,085180,293189,21084,28293,52282,04959,314--9,76343,645245,63565,037----
EBITDA Margin19.5%-0.40-0.49-0.61-0.71-0.44-0.43-0.53-0.56-0.71-0.90-0.63-0.57-0.070.110.330.30-
Interest Expenses15.6%558,268483,122392,939194,22843,03749,0204,056--449573929715489-6,590-
Income Taxes--------9,535-101,354---244,326217,845--43,602-
Earnings Before Taxes14.0%-2,572,851-2,991,224-4,541,839-9,336,317-2,700,473-2,888,655-1,649,872-3,128,833-1,182,159-2,138,231-1,032,951-2,326,828-890,559-6,192-78,377465,389436,373
EBT Margin15.2%-0.51-0.60-0.71-0.82-0.54-0.53-0.64-0.64-0.76-0.94-0.65-0.58-0.080.110.320.29-
Net Income14.0%-2,572,851-2,991,224-4,541,839-9,336,317-2,700,473-2,888,655-1,649,872-3,138,367-1,080,805-2,138,232-1,032,951-2,393,682-890,559-6,192-78,377421,787436,373
Net Income Margin15.2%-0.51-0.60-0.71-0.82-0.54-0.52-0.63-0.63-0.76-0.95-0.66-0.59-0.080.100.310.28-
Free Cashflow61.7%-1,266,332-3,307,258-3,269,645-1,262,750-1,761,369-3,853,438-1,858,793-1,811,406-1,788,021-1,825,370-1,573,173-530,482-429,897-510,281813,429225,752-
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-1.9%71,59172,97272,95332,72733,56837,00738,96638,52632,30518,44120,33613,1197,7626,7645,7674,7694,3553,9413,5263,112
  Current Assets-3.7%21,36822,18821,05912,3208,73411,31513,78812,81217,0249,92611,57012,3477,012--3,497---3,082
    Cash Equivalents-53.6%1,5473,3342,0822,7341,0563,2447,6218,76812,9547,0188,91011,7585,8971,4561,7121,030829--794
  Inventory-7.8%7,5708,2088,6095,5084,4364,6783,4471,6461,284592322156190--100---112
  Net PPE7.2%1,2501,1671,2441,1331,1841,2281,287197224199274113121--34.00---29.00
  Goodwill0%17,80917,80917,8093,7223,7223,7223,7224,8103,6722,7282,728---------
Liabilities1.7%48,83548,00149,38215,4947,7258,2616,9325,8604,7004,1714,3933,3642,3162,7513,1853,6193,8474,0744,3014,529
  Current Liabilities4.9%41,97440,00640,82111,5226,1786,5485,0594,4543,1433,7753,9552,6971,611-3,1283,003---2,170
    LT Debt, Current-----27798.0098.00-------------
Shareholder's Equity-11.0%17,97920,19418,79517,23425,84228,74532,03432,66627,60514,27015,9429,7555,4461,6751,0721,150728---
  Retained Earnings-8.2%-39,537-36,540-33,141-28,237-18,538-15,476-12,225-10,213-6,712-5,390-3,252-2,219175-1,0711,150----1,417
  Additional Paid-In Capital1.4%57,66556,88352,08445,62144,53044,37044,25842,87834,31719,65919,19411,9735,270-------
Shares Outstanding10.6%9,8508,9063,8512,7132,5502,5332,5782,5551,9431,8831,8811,5891,0441,002-1,000----
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations61.7%-1,266-3,307-3,269-1,262-1,761-3,853-1,858-1,811-1,788-1,825-1,573-530-429-510813226----
  Share Based Compensation20.3%232193192160160112288447426466211306280102------
Cashflow From Investing-39.6%-187-134-4,274-87.66-61.88-9.94-16.79-9,010-4,304--1,274-64.57-55.81--98.24-----
Cashflow From Financing-107.1%-3324,6936,8923,029-364-5137286,63512,029-66.66-437*6,4564,928254-32.73-24.57----
  Dividend Payments-100.0%-407362362362362362362------------
  Buy Backs------150--------------

AUVI Income Statement

2023-09-30
Unaudited Condensed Interim Consolidated Statements of Operations - USD ($)
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Net Sales$ 11,446,048$ 5,875,611$ 32,944,217$ 15,139,347
Cost of Goods Sold8,790,7645,036,99725,956,85311,847,842
Gross Profit2,655,284838,6146,987,3643,291,505
Operating Expenses    
Research and development91,08593,522460,588234,885
Selling General and Administrative Expenses5,013,9883,505,09715,200,48610,637,538
Loss on impairment of goodwill and intangibles0001,138,203
Total Operating Expenses5,105,0733,598,61915,661,07412,010,626
Operating Loss(2,449,789)(2,760,005)(8,673,710)(8,719,121)
Other Income (Expense)    
Change in Fair Market Value of Warrant Liability1,20634,8042,12446,521
Interest expense(558,268)(43,037)(1,434,329)(96,113)
Gain (Loss) on change in Fair Market Value of Contingent Consideration434,00001(240,000)
Gain on Settlement of Contingent Consideration (Note 2)0001,700,000
Other Income067,765069,713
Total Other Income (Expense)(123,062)59,532(1,432,204)1,480,121
Loss Before Provision for Income Taxes(2,572,851)(2,700,473)(10,105,914)(7,239,000)
Benefit from Income Taxes0000
Net Loss(2,572,851)(2,700,473)(10,105,914)(7,239,000)
Net Loss attributable to common stockholders:    
Dividends to preferred shareholders(424,750)(362,250)(1,194,231)(1,086,750)
Net Loss attributable to common stockholders$ (2,997,601)$ (3,062,723)$ (11,300,145)$ (8,325,750)

AUVI Balance Sheet

2023-09-30
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets  
Cash and cash equivalents$ 1,546,911$ 2,734,485
Accounts receivable, net of allowance for doubtful accounts6,126,6921,508,239
Costs and estimated earnings in excess of billings2,883,0571,306,762
Inventory, net7,570,3315,508,086
Vendor deposits1,176,06575,548
Prepaid expense and other current assets2,064,8701,187,223
Total Current Assets21,367,92612,320,343
Property and equipment, net of accumulated depreciation1,250,3501,133,468
Other assets431,500153,000
Goodwill17,809,2353,722,077
Other intangible assets, net of accumulated amortization27,334,87011,354,430
Right of use assets3,396,7514,044,109
Total Assets71,590,63232,727,427
Current Liabilities  
Accounts payable and accrued expenses10,278,0762,982,760
Contingent consideration18,375,6720
Deferred revenue6,113,1924,730,299
Due to landlord (Note 2)281,123229,234
Warrant liability7,8639,987
Financing lease obligations42,44533,712
Operating lease liability1,739,0921,437,308
Notes payable, net5,136,6102,098,685
Total Current Liabilities41,974,07311,521,985
Long-Term Liabilities  
Due to landlord - less current portion (Note 2)174,938393,230
Notes payable, net - less current portion4,810,922765,144
Financing lease obligations - less current portion143,575158,070
Operating lease liability - less current portion1,731,9232,655,103
Total Long-Term Liabilities6,861,3583,971,547
Total Liabilities48,835,43115,493,532
Redeemable Preferred Stock  
Temporary Equity, Carrying Amount, Attributable to Parent4,776,4890
Equity  
Common Stock $0.0001 par value, 150,000,000 shares authorized 9,872,228 shares issued and 9,849,531 outstanding as of September 30, 2023 and 2,735,290 shares issued and 2,712,593 outstanding as of December 31, 2022, respectively987274
Additional paid-in capital57,665,01345,620,764
Treasury stock at cost, 22,697, respectively(149,686)(149,686)
Accumulated deficit(39,537,658)(28,237,513)
Total Equity17,978,71217,233,895
Total Liabilities, Redeemable Preferred Stock and Stockholders' Equity71,590,63232,727,427
Series B Redeemable Preferred Stock [Member]  
Redeemable Preferred Stock  
Temporary Equity, Carrying Amount, Attributable to Parent3,712,5000
Series C Redeemable Preferred Stock [Member]  
Redeemable Preferred Stock  
Temporary Equity, Carrying Amount, Attributable to Parent1,063,9890
Series A Preferred Stock [Member]  
Equity  
Preferred Stock, Value, Issued5555
Series X Preferred Stock [Member]  
Equity  
Preferred Stock, Value, Issued$ 1$ 1
AUVI
Applied UV, Inc., through its subsidiaries, develops, acquires, markets, and sells proprietary surface and air disinfection technology. The company operates through Disinfection and Hospitality segments. It also manufactures fine mirrors and custom furniture. The company's products are used in healthcare, hospitality, food preservation, education, winery, and retail industries. The company was incorporated in 2019 and is headquartered in Mount Vernon, New York.
 CEO
 WEBSITEwww.applieduvinc.com
 EMPLOYEES115

Applied UV, Inc. Frequently Asked Questions


What is the ticker symbol for Applied UV, Inc.? What does AUVI stand for in stocks?

AUVI is the stock ticker symbol of Applied UV, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Applied UV, Inc. (AUVI)?

As of Tue Feb 20 2024, market cap of Applied UV, Inc. is 26.04 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AUVI stock?

You can check AUVI's fair value in chart for subscribers.

What is the fair value of AUVI stock?

You can check AUVI's fair value in chart for subscribers. The fair value of Applied UV, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Applied UV, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AUVI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Applied UV, Inc. a good stock to buy?

The fair value guage provides a quick view whether AUVI is over valued or under valued. Whether Applied UV, Inc. is cheap or expensive depends on the assumptions which impact Applied UV, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AUVI.

What is Applied UV, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Feb 20 2024, AUVI's PE ratio (Price to Earnings) is -1.34 and Price to Sales (PS) ratio is 0.69. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AUVI PE ratio will change depending on the future growth rate expectations of investors.